ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,544 | -48.7% | 253,140 | -42.0% | 0.04% | -40.3% |
| Q2 2023 | $8,865 | +13.8% | 436,470 | +2.2% | 0.07% | +10.8% |
| Q1 2023 | $7,792 | +1008.4% | 427,212 | +1156.1% | 0.06% | +550.0% |
| Q4 2022 | $703 | -99.9% | 34,011 | +48.6% | 0.01% | +25.0% |
| Q3 2022 | $599,000 | -65.9% | 22,895 | -67.0% | 0.01% | -63.6% |
| Q2 2022 | $1,758,000 | +87.0% | 69,387 | +132.9% | 0.02% | +83.3% |
| Q1 2022 | $940,000 | +331.2% | 29,787 | +255.0% | 0.01% | +500.0% |
| Q4 2020 | $218,000 | -78.9% | 8,390 | -79.9% | 0.00% | -92.6% |
| Q2 2020 | $1,032,000 | +911.8% | 41,698 | +226.2% | 0.03% | +575.0% |
| Q2 2019 | $102,000 | – | 12,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |